A novel mitogen-inducible gene product related to p50/p105-NF-kappa B participates in transactivation through a kappa B site - PubMed (original) (raw)

A novel mitogen-inducible gene product related to p50/p105-NF-kappa B participates in transactivation through a kappa B site

V Bours et al. Mol Cell Biol. 1992 Feb.

Abstract

A Rel-related, mitogen-inducible, kappa B-binding protein has been cloned as an immediate-early activation gene of human peripheral blood T cells. The cDNA has an open reading frame of 900 amino acids capable of encoding a 97-kDa protein. This protein is most similar to the 105-kDa precursor polypeptide of p50-NF-kappa B. Like the 105-kDa precursor, it contains an amino-terminal Rel-related domain of about 300 amino acids and a carboxy-terminal domain containing six full cell cycle or ankyrin repeats. In vitro-translated proteins, truncated downstream of the Rel domain and excluding the repeats, bind kappa B sites. We refer to the kappa B-binding, truncated protein as p50B by analogy with p50-NF-kappa B and to the full-length protein as p97. p50B is able to form heteromeric kappa B-binding complexes with RelB, as well as with p65 and p50, the two subunits of NF-kappa B. Transient-transfection experiments in embryonal carcinoma cells demonstrate a functional cooperation between p50B and RelB or p65 in transactivation of a reporter plasmid dependent on a kappa B site. The data imply the existence of a complex family of NF-kappa B-like transcription factors.

PubMed Disclaimer

Similar articles

• The ankyrin repeat domains of the NF-kappa B precursor p105 and the protooncogene bcl-3 act as specific inhibitors of NF-kappa B DNA binding.
  Hatada EN, Nieters A, Wulczyn FG, Naumann M, Meyer R, Nucifora G, McKeithan TW, Scheidereit C. Hatada EN, et al. Proc Natl Acad Sci U S A. 1992 Mar 15;89(6):2489-93. doi: 10.1073/pnas.89.6.2489. Proc Natl Acad Sci U S A. 1992. PMID: 1532257 Free PMC article.
• Direct association of pp40/I kappa B beta with rel/NF-kappa B transcription factors: role of ankyrin repeats in the inhibition of DNA binding activity.
  Inoue J, Kerr LD, Rashid D, Davis N, Bose HR Jr, Verma IM. Inoue J, et al. Proc Natl Acad Sci U S A. 1992 May 15;89(10):4333-7. doi: 10.1073/pnas.89.10.4333. Proc Natl Acad Sci U S A. 1992. PMID: 1533932 Free PMC article.
• I-Rel: a novel rel-related protein that inhibits NF-kappa B transcriptional activity.
  Ruben SM, Klement JF, Coleman TA, Maher M, Chen CH, Rosen CA. Ruben SM, et al. Genes Dev. 1992 May;6(5):745-60. doi: 10.1101/gad.6.5.745. Genes Dev. 1992. PMID: 1577270
• NF-kappa B and related proteins: Rel/dorsal homologies meet ankyrin-like repeats.
  Blank V, Kourilsky P, Israël A. Blank V, et al. Trends Biochem Sci. 1992 Apr;17(4):135-40. doi: 10.1016/0968-0004(92)90321-y. Trends Biochem Sci. 1992. PMID: 1533967 Review.
• The inhibitory ankyrin and activator Rel proteins.
  Nolan GP, Baltimore D. Nolan GP, et al. Curr Opin Genet Dev. 1992 Apr;2(2):211-20. doi: 10.1016/s0959-437x(05)80276-x. Curr Opin Genet Dev. 1992. PMID: 1386268 Review.

Cited by

• Thioredoxin regulates the DNA binding activity of NF-kappa B by reduction of a disulphide bond involving cysteine 62.
  Matthews JR, Wakasugi N, Virelizier JL, Yodoi J, Hay RT. Matthews JR, et al. Nucleic Acids Res. 1992 Aug 11;20(15):3821-30. doi: 10.1093/nar/20.15.3821. Nucleic Acids Res. 1992. PMID: 1508666 Free PMC article.
• Structural and functional characterization of the promoter regions of the NFKB2 gene.
  Lombardi L, Ciana P, Cappellini C, Trecca D, Guerrini L, Migliazza A, Maiolo AT, Neri A. Lombardi L, et al. Nucleic Acids Res. 1995 Jun 25;23(12):2328-36. doi: 10.1093/nar/23.12.2328. Nucleic Acids Res. 1995. PMID: 7541912 Free PMC article.
• The NF-kappa B precursor p105 and the proto-oncogene product Bcl-3 are I kappa B molecules and control nuclear translocation of NF-kappa B.
  Naumann M, Wulczyn FG, Scheidereit C. Naumann M, et al. EMBO J. 1993 Jan;12(1):213-22. doi: 10.1002/j.1460-2075.1993.tb05647.x. EMBO J. 1993. PMID: 8428580 Free PMC article.
• Differential regulation of NF-kappaB2(p100) processing and control by amino-terminal sequences.
  Betts JC, Nabel GJ. Betts JC, et al. Mol Cell Biol. 1996 Nov;16(11):6363-71. doi: 10.1128/MCB.16.11.6363. Mol Cell Biol. 1996. PMID: 8887665 Free PMC article.

References

1. 1. Nature. 1991 Aug 22;352(6337):733-6 - PubMed
2. 1. Mol Cell Biol. 1988 May;8(5):2159-65 - PubMed
3. 1. Mol Cell Biol. 1989 Mar;9(3):1041-8 - PubMed
4. 1. Nucleic Acids Res. 1989 Jun 26;17(12):4589-604 - PubMed
5. 1. Mol Cell Biol. 1989 Oct;9(10):4323-36 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon
  • Europe PubMed Central
  • PubMed Central
  • Taylor & Francis

• Other Literature Sources

  • The Lens - Patent Citations Database

• Molecular Biology Databases

  • BioCyc
  • GlyGen glycoinformatics resource

• Research Materials

  • NCI CPTC Antibody Characterization Program